Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 067336/0920 | |
| Pages: | 10 |
| | Recorded: | 05/07/2024 | | |
| Attorney Dkt #: | 167741-030002/US |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
18315472
|
Filing Dt:
|
05/10/2023
|
|
Publication #:
|
|
Pub Dt:
|
12/28/2023
| | | | |
|
Title:
|
N-[2-({4-[3-(ANILINO)-4-OXO-4,5,6,7-TETRAHYDRO-1H-PYRROLO[3,2-C]PYRIDIN-2-YL]PYRIDIN-3-YL)OXY)ETHYL]PROP-2-ENAMIDE DERIVATIVES AND SIMILAR COMPOUNDS AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER
|
|
|
Assignee
|
|
|
|
|
| KAISER-WILHELM-ALLEE 1 |
| LEVERKUSEN, GERMANY 51373 |
|
|
Correspondence name and address
|
| |
MELISSA HUNTER-ENSOR
|
| |
GREENBERG TRAURIG, LLP
|
| |
ONE INTERNATIONAL PLACE, SUITE 2000
|
| |
BOSTON, MA 02110
|
Search Results as of:
05/23/2024 10:28 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
